Zepbound vs. Wegovy: What's the Difference and Which One Is Right for You?
By Allison & Jamie, Verve Wellness
If you've spent any time researching GLP-1 medications, you've probably come across both Zepbound and Wegovy and wondered: what's actually the difference? Are they basically the same thing? Does it matter which one you take?
It matters. Here's what you need to know.
They Work Differently
Both are injectable, once-weekly medications approved for weight loss. But they don't work the same way.
Wegovy contains semaglutide. It targets one receptor in the body — GLP-1 — which helps regulate appetite and blood sugar.
Zepbound contains tirzepatide. It targets two receptors — GLP-1 and GIP. That dual action is what makes it different. Your body gets a stronger, more coordinated signal to reduce hunger and slow digestion.
Think of it this way: Wegovy knocks on one door. Zepbound knocks on two.
The Results Reflect That
Clinical trials for Zepbound showed average weight loss of around 20% of body weight at the highest dose. Wegovy showed around 15%. That's not a small difference, especially if you have 20 or 30 pounds to lose.
We're not saying Wegovy doesn't work — it absolutely does for many people. But when we sit down with a new patient, Zepbound is almost always our first recommendation. The data supports it, and we see it in practice every day.
The Side Effects Are Similar, But Not Identical
Both medications can cause nausea, fatigue, constipation, and decreased appetite — especially in the first few weeks as your body adjusts. These side effects are usually mild and improve over time.
Where they differ: many of our patients report that Zepbound feels smoother. Less nausea, less of that "I can't look at food" feeling that some people experience with semaglutide. That's not universal — every body is different — but it's consistent enough that it factors into how we prescribe.
The appetite suppression on Zepbound also tends to feel more natural. Less white-knuckling, more just... not being hungry. That's a meaningful difference when you're trying to build sustainable habits.
What About Insurance and Cost?
This is where things get complicated, and honestly, it's where most women get tripped up.
Both medications require prior authorization from insurance. Both have a BMI threshold — generally 30 or higher, or 27 with a weight-related condition like PCOS, prediabetes, or hypertension.
Coverage varies a lot by plan. Some plans cover one and not the other. Some cover neither. Some require you to try other options first. This is exactly why having someone in your corner to navigate the process matters — prior authorization paperwork is a whole thing, and most busy women don't have time to fight with their insurance company.
At Verve, we handle that process with you.
So Which One Should You Take?
Honestly? For most of our patients, Zepbound. Stronger appetite suppression, better tolerability in our experience, and outcomes that speak for themselves.
That said, there are cases where Wegovy makes more sense — insurance coverage being the most common reason, or a patient who has specific clinical factors that make semaglutide a better fit. This is why a real consultation matters. Not a quiz. Not an algorithm. An actual conversation with a clinician who knows your history.
Ready to Figure Out Which One Is Right for You?
We're Allison and Jamie — a registered nurse and nurse practitioner based in New York and Connecticut. We started Verve because we kept seeing women get handed a prescription with no real support behind it. That's not how we do things.
If you're in NY or CT and want to talk through your options, we'd love to meet you. No commitment, no pressure — just a real conversation.
Results vary. Medications are prescribed only when clinically appropriate. All care is provided by licensed medical professionals.
